Stockscreener 앱 받기
2.11
0.94%
-0.02
전일 마감가:
$2.13
열려 있는:
$2.1
하루 거래량:
76,500
Relative Volume:
0.59
시가총액:
$211.87M
수익:
-
순이익/손실:
$-60.14M
주가수익비율:
-2.9739
EPS:
-0.7095
순현금흐름:
$-68.17M
1주 성능:
+1.93%
1개월 성능:
+1.93%
6개월 성능:
-20.08%
1년 성능:
-37.39%
1일 변동 폭
$2.07
$2.1901
1주일 범위
$2.04
$2.25
52주 변동 폭
$1.4299
$3.98
Ac Immune Sa Stock (ACIU) Company Profile
ACIU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.11 | 214.28M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.81 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.33 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.52 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.28 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.20 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-31 | 개시 | BTIG Research | Buy |
| 2019-02-01 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-01-04 | 개시 | UBS | Buy |
| 2018-04-05 | 개시 | H.C. Wainwright | Buy |
| 2018-03-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | 개시 | Credit Suisse | Outperform |
| 2016-10-18 | 개시 | Jefferies | Buy |
| 2016-10-18 | 개시 | Leerink Partners | Outperform |
모두보기
Ac Immune Sa 주식(ACIU)의 최신 뉴스
Visual analytics tools that track AC Immune SA performanceJuly 2025 Momentum & Free High Return Stock Watch Alerts - Newser
News impact scoring models applied to AC Immune SA2025 Analyst Calls & Entry Point Strategy Guides - Newser
Using AI based signals to follow AC Immune SAEarnings Trend Report & Trade Opportunity Analysis Reports - Newser
Ranking AC Immune SA among high performing stocks via toolsOptions Play & Risk Controlled Stock Pick Alerts - Newser
Identifying reversal signals in AC Immune SAPortfolio Update Summary & Consistent Profit Trading Strategies - Newser
How to integrate AC Immune SA into portfolio analysis toolsJuly 2025 Summary & Daily Stock Momentum Reports - Newser
When is the best time to exit AC Immune SAAnalyst Downgrade & Real-Time Buy Signal Alerts - Newser
Using data models to predict AC Immune SA stock movementProfit Target & Risk Controlled Swing Alerts - Newser
How to use Fibonacci retracement on AC Immune SAEarnings Overview Report & Safe Entry Point Identification - Newser
Chart based exit strategy for AC Immune SAMarket Rally & Weekly Market Pulse Updates - Newser
Can AC Immune SA disrupt its industryJuly 2025 Chart Watch & High Accuracy Investment Signals - sundaytimes.kr
AC Immune SA Included in Top Momentum ScanQuarterly Market Summary & High Yield Equity Trading Tips - thegnnews.com
What momentum shifts mean for AC Immune SATrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Why AC Immune SA stock attracts strong analyst attention2025 Retail Activity & Safe Entry Zone Identification - Newser
Advanced analytics toolkit walkthrough for AC Immune SAInflation Watch & Safe Entry Point Identification - Newser
Developing predictive dashboards with AC Immune SA dataOil Prices & Growth Focused Stock Reports - Newser
Backtesting results for AC Immune SA trading strategiesLow Exposure Strategy with Sector Analysis - Newser
Using R and stats models for AC Immune SA forecastingInvestment Timeline and ROI Summary Report - Newser
Is AC Immune SA stock poised for growthAI Swing Strategy Signal Forecasting System - Newser
Analyzing drawdowns of AC Immune SA with statistical toolsSupport and Resistance Zone Summary Chart - Newser
Is AC Immune SA reversing from oversold territoryFree Capital Preserving Trade Plan Templates - Newser
Can machine learning forecast AC Immune SA recoveryFree High Accuracy Alerts for ROI Traders - Newser
What makes AC Immune SA stock price move sharplyForecasting Stock Moves with AI Insights - Newser
Can AC Immune SA expand its profit marginsSmart Beta Portfolio Candidates - sisaissue.com
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune Reports Q2 2025 Financial Progress - The Globe and Mail
Q3 Earnings Forecast for AC Immune Issued By Leerink Partnrs - Defense World
Visualizing AC Immune SA stock with heatmapsFree Weekly Growth Stock Entry Point Alerts - Newser
Ac Immune Sa (ACIU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.30%
자본화:
|
볼륨(24시간):